Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202008761557201Phase 3Recruiting
Phase 3, open-label trial of dexmedetomidine and propofol (2 arms), sponsored by Mona Raafat Elghamry. Primary endpoint: Recovery time. Started Aug 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202008761557201.